Latest News and Press Releases

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Veterinary Active Pharmaceutical Ingredients (API) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added...

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "United States Small Molecule Innovator API CDMO Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to ...

Olon Group, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech.

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "High Potency Active Pharmaceutical Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of...

MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...

MILAN, 04 nov. 2024 (GLOBE NEWSWIRE) -- Olon, fournisseur d’API et acteur mondial dans le domaine des CDMO, confirme le respect du calendrier de construction de sa nouvelle installation dédiée aux...

Olon is ready to host productions in the new facility dedicated to ultra-potent compounds

Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "High Potency APIs (HPAPIs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for High...

Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)" report has been added to ...